What is Sitagliptin?

Category: Prescription Drugs

Most popular types: Januvia

false

Sitagliptin is an antidiabetic agent use in the treatment of noninsulin dependent diabetes as an adjunct to diet and exercise as a single agent or in combination therapy with other antidiabetic agents.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Diabetes type 2 1876 71
Weight gain 4 1
Elevated blood sugar (hyperglycemia) 3 0
Anxious mood 1 0
Bowel problems 1 0

Show all 18 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 9
Moderate 4
Mild 8
None 59

Commonly reported side effects and conditions associated with Sitagliptin

Side effect Patients Percentage
Abdominal pain 1
Breathlessness 1
Chronic diarrhea 1
Decreased appetite 1
Elevated blood sugar (hyperglycemia) 1
Frequent daytime urination 1

Show all 19 reported side effects

Why patients stopped taking Sitagliptin

Multiple reasons could be selected

Reason Patients Percentage
Doctor's advice 24
Did not seem to work 14
Side effects too severe 11
Change in health plan coverage 6
Expense 6
Other 6
Course of treatment ended 2
Personal research 1
See all 57 patients who've stopped taking Sitagliptin

Duration

Stopped taking Sitagliptin

Duration Patients Percentage
Less than 1 month 10
1 - 6 months 8
6 months - 1 year 8
1 - 2 years 12
2 - 5 years 13
5 - 10 years 6
Adherence
Adherence Evaluations Percentage
Always 67
Usually 5
Sometimes 2
Never taken as prescribed 6
Burden
Burden Evaluations Percentage
Very hard to take 6
Somewhat hard to take 4
A little hard to take 4
Not at all hard to take 66
Cost per month
Cost per month Evaluations Percentage
$200+ 3
$100-199 1
$50-99 8
$25-49 10
< $25 31
Not specified 27

What people switch to and from

Patients started taking Sitagliptin after stopping:

Treatment Patients Percentage
Metformin (Metformin ER) 17
Glipizide (Glipizide ER) 5
Insulin Glargine (Lantus) 3
Dapagliflozin (Farxiga) 2
Linagliptin (Tradjenta) 2

Show all 13 treatments patients report switching from

Patients stopped taking Sitagliptin and switched to:

Treatment Patients Percentage
Metformin (Metformin ER) 6
Sitagliptin-metformin (Janumet) 6
Insulin Glargine (Lantus) 5
Canagliflozin (Invokana) 3
Dulaglutide (Trulicity) 3

Show all 20 treatments patients report switching to

Last updated:

2 patient evaluations for Sitagliptin

Jun 25, 2012 (Started May 26, 2012)

  • Effectiveness
    Major (for diabetes type 2)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 50 mg Daily
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost: < $25 monthly

  • 0 helpful marks

Jul 1, 2011 (Started Jul 01, 2010)

  • Effectiveness
    None (for diabetes type 2)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 50 mg Daily
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost: $25-49 monthly

  • 0 helpful marks
Last updated:
Showing 2 of 2 patient evaluations for Sitagliptin